FINWIRES · TerminalLIVE
FINWIRES

February Annual Home Price Growth Decelerates as Housing Slowdown Broadens, S&P Says

By

-- US home price growth decelerated annually in February, with more than half of major metropolitan markets logging decreases, S&P Global (SPGI) division S&P Dow Jones Indices said Tuesday.

The national S&P Cotality Case-Shiller Index rose 0.7% year over year in February without seasonal adjustments, down from a 0.8% increase the month prior. The 10- and 20-city composites increased 1.5% and 0.9%, respectively, both slowing down from January's growth rates.

"More than half of major US metropolitan markets posted year-over-year price declines in February, signaling that the housing slowdown has broadened well beyond its Sun Belt origins," said Nicholas Godec, head of fixed income tradables and commodities at S&P Dow Jones Indices. "With consumer inflation at 2.4%, US home values have lost ground in real terms for nine consecutive months."

Among the 20 cities, Chicago saw the highest annual gain in prices in February, up 5%, followed by New York and Cleveland. Denver logged the lowest return, down 2.2%, according to the report.

Sequentially, pre-seasonally adjusted national home prices increased 0.3% in February, compared with the previous month's 0.2% decline. The 10-city composite index was up 0.6%, while the 20-city composite increased 0.4%, the data showed.

"Monthly data offered a modest seasonal lift without underlying momentum," Godec said. "Mortgage rates near 6% continue to weigh on affordability and transaction activity, holding nominal price growth below inflation."

Separately, the Federal Housing Finance Agency said US home prices were unchanged sequentially in February after January's 0.1% gain was revised upward to 0.2%. Annually, prices increased 1.7% in February, according to the report.

Price: $444.38, Change: $+7.16, Percent Change: +1.64%

Related Articles

Treasury

Bank of Canada Keeps Neutral Rate Unchanged and Looks Likely to Stay on Hold This Year, Says BMO

The Bank of Canada is potentially on a long hiatus from policy rate changes, assuming growth and inflation evolve roughly in-line with current expectations, said Bank of Montreal (BMO).Consistent with that, the BoC on Wednesday left the assumed neutral range unchanged at 2.25%-to-3.25% in its annual April refresh, noted the bank.That leaves the current policy rate right at the low end of the presumed range.Holding the neutral rate down is the stall in population growth and the drag that it has had on labor force growth, stated BMO.Holding the neutral rate up is some improvement in productivity growth and firmness -- even a touch of upside -- in the United States neutral rates, which have an impact on Canada, according to the bank.All things considered, BMO is comfortable with its view that the BoC is on hold this year.

$$CXY
Asia

Zhangzhou Pientzehuang Pharmaceutical's Attributable Profit Slides 26% in Q1

Zhangzhou Pientzehuang Pharmaceutical's (SHA:600436) attributable profit fell 26% to 743.5 million yuan in the first quarter from 999.8 million yuan in the year-ago period, according to a Thursday filing with the Shanghai bourse.Earnings per share at the drug company decreased to 1.23 yuan from 1.66 yuan in the prior-year period.Operating revenue declined 13% year over year to 2.74 billion yuan from 3.14 billion yuan.

$SHA:600436
Research

CICC Starts Ongoal Technology at Outperform with 185 Yuan Price Target

$SHE:301662